The economic cost of musculoskeletal disorders in Canada.
This study estimated the total cost of musculoskeletal disorders for Canadians in 1994 and assessed the sensitivity of these cost estimates to variations in the definition of musculoskeletal disorders.
Disease-related costs, from a societal perspective, were measured using a prevalence-based analysis.
First, direct treatment costs, including expenditures on hospitals and other institutions, physicians and other health professionals, drugs, research, and other items were assessed.
Second, indirect costs associated with lost (or foregone) productivity due to disability and premature mortality were evaluated using the human capital approach.
The total cost of musculoskeletal disorders in Canada was $25.6 billion (in 1994 Canadian dollars, $1.00 CDN $0.75 US) or 3.4% of the gross domestic product.
Direct and indirect costs were estimated at $7.5 billion and $18.1 billion, respectively.
Lower and upper bound estimates of the total cost of musculoskeletal disorders, derived from the sensitivity analysis, were $19.9 billion and $30.8 billion, respectively.
Wide variations were reported in the total cost of various musculoskeletal disorder subcategories, with the highest costs reported for injuries ($10.7 billion), back and spine disorders ($8.1 billion), and arthritis and rheumatism ($5.9 billion). (...)
Mots-clés Pascal : Système ostéoarticulaire pathologie, Orthopédie, Rhumatologie, Epidémiologie, Prévalence, Incapacité, Analyse coût, Méthodologie, Canada, Amérique du Nord, Amérique, International Classification of Diseases 9, Homme
Mots-clés Pascal anglais : Diseases of the osteoarticular system, Orthopedics, Rheumatology, Epidemiology, Prevalence, Disability, Cost analysis, Methodology, Canada, North America, America, International Classification of Diseases 9, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0530918
Code Inist : 002B15I. Création : 23/03/1999.